Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05375045

Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants

Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Clermont Ferrand

Clermont-Ferrand, 63003, France

Location status: Recruiting

Location contact

Christophe DESCHAUMES, Pr

CONTACT

[email protected]

06 81 12 42 07 ext. +033

About this study

Many adults have one or more missing teeth. The negative consequences of partial or total edentulousness are numerous at the level of the orofacial sphere :

  • Edentulism generates a strong aesthetic deficit due to the lack of support of the tissues and the facial musculature;
  • Edentulism causes a functional deficit that can have significant repercussions on the nutritional status of the affected subject;
  • Edentulism is accompanied by bone resorption of the jaws which is unavoidable in the absence of implant treatment;
  • In addition, the resulting feelings of discomfort and fragility are experienced as a real psychological handicap by the patient, partially or totally edentulous, which can then have significant repercussions on his social life.

EUROTEKNIKA dental implants are intended to be used for the replacement of a dental root in order to support a fixed or mobile prosthesis and thus restore masticatory function. EUROTEKNIKA dental implants are made of titanium or titanium alloy for surgical implants in accordance with ISO5832-2 and -3 standards.

EUROTEKNIKA dental implants are intended for use in cases of single, partial or complete edentulism on the maxillary and/or mandibular arch:

  • Single tooth loss,
  • Intercalary toothlessness,
  • Terminal toothlessness,
  • Total edentulism.

Dental implantology is based on the following principle: an implant is surgically inserted into the maxilla or mandible, and then a pillar is connected to this implant to support the dental prosthesis.

The use of dental implants is based on a biological process called osseointegration. Osseointegration corresponding to the fact that certain materials such as titanium are able to form direct contact with the surrounding bone. Osseointegration is therefore the direct structural and functional connection between living bone and the surface of an artificial implant. In order to allow the osseointegration process, and depending on the clinical case, a more or less long healing period must be observed before connecting the prosthetic elements to the implant. In cases of immediate loading, there is no healing period.

The expected benefits of this surgery are to improve the quality of life of patients and to recover masticatory function.

The claimed clinical performances are:

  • High primary stability,
  • High long-term implant stability,
  • Limitation of bone resorption and risks of mucositis and peri-implantitis
  • Maintenance of soft tissues.

The objectives of this study are therefore to assess the safety and performance of EUROTEKNIKA dental implants.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged 18 or over
  • Patient who has completed bone growth
  • Patient informed and agreeing to participate in the study
  • Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort)
  • Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort)
  • Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort)
  • Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)

Exclusion criteria

  • Pregnant or breastfeeding women (for the prospective cohort)
  • Patient with bone disease in the cervico-facial region
  • Patient refusing to participate in the study
  • Patient with at least one contraindication to implantation (for the prospective cohort)
  • Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort)
  • Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort)
  • Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort)
  • Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)

Treatment and study plan

dental implantation

Device

an implant is surgically inserted into the maxilla or mandible, and then an abutment is connected to this implant to support the dental prosthesis.

Primary outcomes

  1. The success rate of tissue integration of the implant

    Time frame: 5 years after implantation

    Integration of the implant 5 years after implantation

Secondary outcomes

  1. assessment of the quality of life of patients following the recovery of full dentition with the GOHAI score (General Oral Health Assessment Index)

    Time frame: 5 years after implantation

    the quality of life of patients will be evaluated with the GOHAI score before implantation and 5 years after implantation

  2. Complication rate taking into account pain, local tenderness, infection, mobility of the implant, fracture

    Time frame: 5 years after implantation

    pain, local tenderness, infection, mobility of the implant, fracture will be collected during the 5 years follow-up

  3. measuring chewing function after prosthesis placement

    Time frame: 5 years after implantation

    Occlusal assessment will be performed after implantation and at 5 years follow-up

  4. Rate of inflammation (visual)

    Time frame: 5 years after implantation

    Assessment of inflammation with visual examination 5 years after implantation

  5. Assessment of the evolution of the péri-implant tissues

    Time frame: 5 years after implantation

    assessment of the evolution of the péri-implant tissues with the Pink esthetic score

  6. assessment of the osseointegration of the implant

    Time frame: 5 years after implantation

    assessment of the osseointegration of the implant with the ISQ score

  7. Rate of infection (x-ray)

    Time frame: 5 years after implantation

    Assessment of infection with radiographic examination 5 years after implantation

Sponsors and collaborators

Lead sponsor

Euroteknika

Industry

Collaborators

  • EVAMED

Registry information

Important dates

Study start
2022
Primary completion
2027
Study completion
2028
First posted
May 16, 2022
Registry last updated
May 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.